A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)

NCT04641975 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Stopped Termination due to operational futility

Conditions

Overactive Bladder (OAB)
Pharmacokinetics of Mirabegron

Interventions

DRUG: Mirabegron
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.